Stock Spotlights Archives - Page 368 of 422

MondayDec 11, 2017 2:45 pm

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Utilizes Proprietary Advanced Biosynthesis Process to Develop Cannabinoids-based Therapies

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) remains focused on discovering potential breakthrough cannabinoid-based therapies by utilizing its proprietary cannabinoid biosynthesis process and its bioinformatics drug and disease targeting tool. An article discussing this reads: “Other biopharmaceutical companies may produce cannabinoids in the laboratory using chemical synthesis, but there’s a litany of drug development efforts with synthetic molecules that have failed. The proprietary biosynthesis process used by InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) is unique. Producing cannabinoids that are identical to naturally occurring compounds is transformative for drug development. By using its proprietary process, InMed is able to manufacture exact…

MondayDec 11, 2017 2:45 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Sets its Sights on Booming Global Cannabis Industry

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) patented delivery technology, DehydraTECH™ has positioned the company at the forefront of the thriving global cannabis industry. A recent article discussing this reads: “LXRP’s technology enables improved delivery of bioactive substances via oral ingestion that results in increased absorption without the need for unhealthy practices of inhalational dosing that result in damaging affects to the lungs. The technology also eliminates the need for co-administration with unhealthy sugars or sweeteners in delivery that are commonly used to mask the bitter tastes. With DehydraTECH™, bioactive substance delivery is improved by combining molecules with certain fatty acids…

MondayDec 11, 2017 2:37 pm

NetworkNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Develops Cannabis-Based Therapeutics in Response to Opioid Epidemic

Emerging pharmaceutical and IP development company Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is using scientific research and development to stake out its spot in the medical marijuana industry. An article discussing this reads: “Veritas Pharma’s mission is to develop and commercialize the most effective cannabis strains, backed by clinical data. This innovative research and development path aims to solve the critical need for real science to support claims surrounding medical marijuana. The company’s approach, combined with its strategic alliances, will effectively address the medical community’s concerns over the complexities of cannabis potency, efficacy, quality and content in the…

MondayDec 11, 2017 2:35 pm

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Holds Interests in Key Mineral Rights to a Region Rich with Potential

Due to its unique properties that allow electric cars to extend range between charges, the demand for cobalt is expected to sky-rocket. It is projected that 75 percent of lithium-ion batteries will contain cobalt by 2020 (http://nnw.fm/K8M9u). First Cobalt (TSX.V: FCC) (OTCQB: FTSSF) is at the forefront of this demand and positioned as a global resource in rapidly assembling one of the world’s largest pure-play cobalt portfolios. A recent article highlights the company’s interests in a region ripe with potential stating, “The company holds interests in key mineral rights in a region that boasts historic production of 50 million pounds…

FridayDec 08, 2017 12:19 pm

NetworkNewsBreaks – Skinvisible, Inc. (SKVI) Poised for Growth More than Skin Deep

Skinvisible (OTCQB: SKVI) is poised for growth in the booming global topical drug delivery market. A recent article highlights the company’s positioning, stating, “The Nevada-based Company, which develops topical, transdermal and mucosal polymer-based drug delivery systems and formulations that incorporates its patent-pending technology for combining hydrophilic and hydrophobic polymer, is a player in an industry poised to double in size over the next seven years. A new market research report estimates the global topical drug delivery market will grow at a CAGR of 9.2% from USD 101.7 billion in 2016 to reach USD 205.1 billion by 2024. This is good…

FridayDec 08, 2017 12:18 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) DehydraTech™ Shines in Vegas Lights

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) attracted a lot of attention in Las Vegas at this year’s Marijuana Business Conference & Expo due to increased awareness about potential health benefits of cannabinoids and an increased demand for improved CBD-based edibles. A recent article highlights keen interest in Lexaria’s patented DehydraTECH™ delivery technology, stating, “Lexaria’s proprietary technology has been awarded patents in the U.S. and Australia, and it has patents pending in more than 40 other countries. Furthermore, it is the only company in the world to date that has a patent allowed for the oral delivery of all non-psychoactive cannabinoids,…

FridayDec 08, 2017 12:16 pm

NetworkNewsBreaks – RJD Green Inc.’s (RJDG) Healthcare Payment Solution

RJD Green (OTC: RJDG) provides solutions to meet the growing digital needs for industries in various sectors. A recent article highlights an innovative RJDG solution for the health care industry, stating, “RJDG’s IOSOFT Inc. is providing discrete payment applications through software and services being incorporated into health care provider networks, enabling hospitals, individual providers and health care payers to work together more seamlessly. IOSOFT software applications are being integrated by third party administrators and other medical services providers nationally.” To view the full article, visit http://nnw.fm/qL2OP About RJD Green, Inc. The company operates as a holding company with a focus…

FridayDec 08, 2017 12:15 pm

NetworkNewsBreaks – Tapinator, Inc. (TAPM) Tapping into Revenue for Existing Games

Tapinator (OTCQB: TAPM) has implemented a strategy for enhancing engagement and increasing revenue for existing games, which positions the company in the strong global mobile gaming market that Statista.com forecasts will have grown to $188.9 billion by 2020. A recent article highlights Tapinator’s strategy for tapping into this revenue stream, stating, “As reflected in a recent Morningstar article titled, ‘Should You Stuff Your Stocking With Video Game Stocks?’ (http://nnw.fm/0AGSe), TAPM’s strategies for enhancing the engagement of current users and increasing revenue from existing games is right in line with industry leaders and presents a ripe opportunity to increase revenue and…

FridayDec 08, 2017 12:15 pm

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science

Amid the requirements for maintaining uncompromised sampling in laboratory research, Pressure BioSciences, Inc. (OTCQB: PBIO) is delivering a proprietary technology that can control the preparation of scientific samples in a critical and unprecedented way. This allows researchers to begin their experimentation with the assurance of using biological products that are unmatched in their quality and most likely to produce sound science as a result. An article discussing this reads: "PBIO’s product line is based on a patented, enabling technology platform called pressure cycling technology (PCT), which employs alternating cycles of hydrostatic pressure — ranging between ambient (14.5 psi) and ultra-high…

FridayDec 08, 2017 12:14 pm

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Targets Massive CBD Market Through Eqova Life Sciences Subsidiary

Grey Cloak Tech (OTCQB: GRCK) is positioning itself to profit from the growing cannabinoid (“CBD”) market through its wholly owned subsidiary Eqova Life Sciences. An article discussing this reads: “Eqova Life Sciences recently exhibited the company’s CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company’s formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Breaks Categories: Stock Spotlights